TYSABRI (natalizumab)

(Abst.) Risk of postpartum disease activity with subcutaneous vs. IV natalizumab in pregnant women w/MS

Started by agate on 01 Mar, 2026 20:42

Views: 12, Replies: 0

(Abst.) Managing reactivation of MS during treatment w/natalizumab

Started by agate on 20 Dec, 2025 16:01

Views: 10, Replies: 0

Tysabri-related PML cases

Started by agate on 26 Mar, 2017 13:51
Last post by agate on 30 Aug, 2025 21:28

Views: 961, Replies: 6

(Abst.) Natalizumab for MS [Cochrane Database Sys Rev]

Started by agate on 07 Aug, 2025 07:01

Views: 13, Replies: 0

Should natalizumab be used despite JC virus positivity?

Started by agate on 05 Jun, 2025 20:51

Views: 15131, Replies: 0

(Abst.) Subq administration of natalizumab can lead to lower drug concentrations compared to IV

Started by agate on 05 Aug, 2024 14:59

Views: 486, Replies: 0

(Abst.) Altered lymphocyte profiles and [shingles] infections in MS patients on natalizumab

Started by agate on 17 Jun, 2024 13:52

Views: 357, Replies: 0

Fatigue and processing speed in PwMS treated with Tysabri or Rituxan

Started by agate on 03 Jun, 2024 07:40

Views: 448, Replies: 0

(Abst.) Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy

Started by agate on 22 Dec, 2023 14:22

Views: 364, Replies: 0

Tysabri biosimilar for relapsing MS under FDA review

Started by agate on 27 Jul, 2022 20:12
Last post by agate on 30 Aug, 2023 21:19

Views: 559, Replies: 2

(Abst.) Developing a model of care for home infusions of Tysabri...

Started by agate on 08 Nov, 2019 08:48
Last post by agate on 19 May, 2023 21:35

Views: 1205, Replies: 4

Biogen Seeks preliminary injunction in case against Sandoz

Started by agate on 28 Oct, 2022 21:38

Views: 350, Replies: 0

(AAN) PML risk cut by extending Tysabri dosing interval

Started by agate on 27 Apr, 2018 14:23
Last post by agate on 05 Jun, 2022 16:37

Views: 703, Replies: 5

(ACTRIMS) PML incidence rates in US patients treated w/natalizumab

Started by agate on 28 Feb, 2022 21:03

Views: 288, Replies: 0

(Abst.) MS disease activity and disability after discontinuing Tysabri for pregnancy

Started by agate on 25 Jan, 2022 21:03

Views: 433, Replies: 0

JCV mutations may predict Tysabri-related PML

Started by agate on 04 Oct, 2021 16:39

Views: 294, Replies: 0

European Commission grants marketing authorization for subcutaneous Tysabri

Started by agate on 07 Apr, 2021 20:38
Last post by agate on 06 May, 2021 21:04

Views: 537, Replies: 1

(Abst.) PML and the spectrum of JC virus-related disease

Started by agate on 22 Nov, 2020 11:44

Views: 287, Replies: 0

TYSABRI (natalizumab)